{"id":"technetium-99mtc-nofetumomab-merpentan","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Nuclear medicine imaging procedure","category":"indication"},{"label":"Boehringer Ingelheim","category":"company"},{"label":"Approved 1990s","category":"decade"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Boehringer Ingelheim","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=technetium (99mTc) nofetumomab merpentan","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:19:20.010438+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:19:25.603272+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=technetium (99mTc) nofetumomab merpentan","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:19:25.932802+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109287/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:19:27.183569+00:00"}},"allNames":"verluma","offLabel":[],"synonyms":["Tc-99m-nofetumomab merpentan","technetium (99mTc) nofetumomab merpentan","nofetumomab","technetium Tc 99m nofetumomab merpentan","verluma","NR-LU-10"],"timeline":[{"date":"1996-08-20","type":"positive","source":"DrugCentral","milestone":"FDA approval (Boehringer Ingelheim)"}],"approvals":[{"date":"1996-08-20","orphan":false,"company":"BOEHRINGER INGELHEIM","regulator":"FDA"}],"brandName":"Verluma","ecosystem":[{"indication":"Nuclear medicine imaging procedure","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Verluma is a small molecule radiopharmaceutical that is labeled with technetium-99m (99mTc), a radioactive isotope. It is administered to patients and accumulates in specific tissues or organs, allowing for imaging and diagnosis."},"commercial":{"launchDate":"1996","_launchSource":"DrugCentral (FDA 1996-08-20, BOEHRINGER INGELHEIM)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5041","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=technetium (99mTc) nofetumomab merpentan","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:48:34.883165","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:19:28.967184+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"technetium (99mtc) nofetumomab merpentan","indications":{"approved":[{"name":"Nuclear medicine imaging procedure","source":"DrugCentral","snomedId":373205008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"1N9O74Y20W","VANDF":"4007960","INN_ID":"7542","UMLSCUI":"C0669084","chemblId":"CHEMBL2109287","ChEMBL_ID":"CHEMBL2109287","KEGG_DRUG":"D09011","DRUGBANK_ID":"DB09336","SNOMEDCT_US":"440507005","MESH_SUPPLEMENTAL_RECORD_UI":"C109626"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1996-","companyName":"Boehringer Ingelheim","relationship":"Original Developer"}],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Boehringer Ingelheim","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Boehringer Ingelheim","companyId":"boehringer-ingelheim","modality":"Small Molecule","firstApprovalDate":"1996","aiSummary":"Verluma is a diagnostic agent used in the diagnosis of various types of cancer, including lung, gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma. It is a technetium-99m (99mTc) labeled antibody derivative, specifically a mouse monoclonal antibody derivative attached to the chelator merpentan.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1996-08-20T00:00:00.000Z","mah":"BOEHRINGER INGELHEIM","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:19:28.967184+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}